Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2021-07-22 Interim / Quarterly Rep…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Karo Pharma Quarterly report Q2 – 2021' and contains comprehensive financial statements, including consolidated income statements, balance sheets, cash flow statements, and management commentary (CEO comments). It covers a period shorter than a full fiscal year (April-June 2021). It meets the criteria for an Interim/Quarterly Report as it provides substantive financial data and analysis rather than just an announcement. Q2 2021
2021-07-22 English
Karo Pharma to sell its treasury shares
Transaction in Own Shares Classification · 99% confidence The document is a press release titled "Karo Pharma to sell its treasury shares." It explicitly details the sale of 1,375,417 treasury shares to Karo Intressenter AB for capital enhancement purposes. This action—the company buying back or selling its own shares (treasury shares)—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2021-05-06 English
Karo Pharma säljer egna aktier
Transaction in Own Shares Classification · 99% confidence The document is a press release from Karo Pharma dated May 6, 2021, titled "Karo Pharma säljer egna aktier" (Karo Pharma sells own shares). The content explicitly details the sale of the company's treasury shares (1,375,417 shares) to a related party (Karo Intressenter AB) to strengthen financial flexibility. This action—the company buying back or selling its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2021-05-06 Swedish
Karo Pharma beslutar om försäljning av egna aktier
Transaction in Own Shares Classification · 98% confidence The document is a press release from Karo Pharma dated April 28, 2021, titled "Karo Pharma beslutar om försäljning av egna aktier" (Karo Pharma decides on the sale of own shares). The content explicitly details the board's decision to sell up to 1,768,000 treasury shares to increase financial flexibility, referencing authorization from the 2021 Annual General Meeting and specifying the execution venue (Nasdaq Stockholm). This action—the company buying back or selling its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2021-04-28 Swedish
Karo Pharma resolves on sale of own shares
Transaction in Own Shares Classification · 98% confidence The document is explicitly titled a "Press release" dated April 28, 2021, and its subject is "Karo Pharma resolves on sale of own shares." It details the Board of Directors' resolution to sell up to 1,768,000 own shares using authorization from the 2021 AGM. This action—the company buying back or selling its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2021-04-28 English
ÅRSSTÄMMA 2021 i KARO PHARMA AKTIEBOLAG
AGM Information Classification · 99% confidence The document text is titled 'ÅRSSTÄMMA 2021 i KARO PHARMA AKTIEBOLAG' (Annual General Meeting 2021 in Karo Pharma AB). It details the decisions made during the meeting, including the approval of financial statements, election/re-election of board members (Patrick Smallcombe elected Chairman), approval of remuneration, appointment of auditors (Ernst & Young AB), and authorization for share transfers and emissions. These are all core components of the proceedings and outcomes of an Annual General Meeting. Therefore, the classification is AGM-R (AGM Information). The document length (3175 chars) is substantial enough to be the report/minutes itself, not just an announcement of the meeting.
2021-04-21 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.